- Open Access
The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection
Gut Pathogens volume 8, Article number: 21 (2016)
Human Campylobacter jejuni infections are worldwide on the rise. Information about the distinct molecular mechanisms underlying campylobacteriosis, however, are scarce. In the present study we investigated whether cytokines including IL-23, IL-22 and IL-18 sharing pivotal functions in host immunity were involved in mediating immunopathological responses upon C. jejuni infection.
To address this, conventionally colonized IL-23p19−/−, IL-22−/− and IL-18−/− mice were perorally infected with C. jejuni strain ATCC 43431. Respective gene-deficient, but not wildtype mice were susceptible to C. jejuni infection and could be readily colonized with highest pathogenic loads in the terminal ileum and colon at day 14 postinfection (p.i.). In IL-23p19−/−, IL-22−/− and IL-18−/− mice viable C. jejuni were detected in MLNs, but did not translocate to spleen, liver, kidney and blood in the majority of cases. Susceptible IL-22−/−, but neither IL-23p19−/−, nor IL-18−/− mice harbored higher intestinal commensal E. coli loads when compared to resistant wildtype mice. Alike C. jejuni, commensal E. coli did not translocate from the intestinal to extra-intestinal tissue sites. Despite C. jejuni infection, mice lacking IL-23p19, IL-22 or IL-18 exhibited less apoptotic cells, but higher numbers of proliferating cells in their colonic epithelium as compared to wildtype mice at day 14 p.i. Less pronounced apoptosis was parallelled by lower abundance of neutrophils within the colonic mucosa and lamina propria of infected IL-23p19−/− and IL-22−/− as compared to wildtype control mice, whereas less distinct colonic TNF secretion could be measured in IL-22−/− and IL-18−/− than in wildtype mice at day 14 p.i. Notably, in infected IL-22−/− mice, colonic IL-23p19 mRNA levels were lower, whereas the other way round, colonic IL-22 expression rates were lower in IL-23p19−/− mice as compared to wildtype controls. Moreover, IL-18 mRNA was less distinctly expressed in large intestines of naive and infected IL-22−/− mice, but not vice versa, given that IL-22 mRNA levels did not differ between in IL-18−/− and wildtype mice.
Cytokines belonging to the IL-23/IL-22/IL-18 axis mediate immunopathological responses upon murine C. jejuni infection in a differentially orchestrated manner. Future studies need to further unravel the underlying regulatory mechanisms orchestrating pathogenic-host interaction.
The Gram-negative bacterium Campylobacter jejuni represents a major agent causing food-borne gastroenteritis in humans with rising incidences worldwide [1, 2]. In many wild and domestic animal species, C. jejuni is part of the commensal intestinal microbiota. Zoonotic transmission from livestock animals to humans commonly takes place via consumption of contaminated meat products or water [3–5]. C. jejuni infected individuals present a broad range of symptoms including mild, non-inflammatory, and watery diarrhea, but also severe, inflammatory, bloody diarrhea associated with abdominal cramps that might last for up to a few weeks, that usually resolve spontaneously [6–8]. In rare cases, however, post-infectious sequelae such as reactive arthritis and peripheral neuropathies including Guillain–Barré and Miller–Fisher syndromes might arise later on [6, 9]. Acute campylobacteriosis is characterized by histological changes of the large intestinal mucosa including apoptosis, crypt abscesses, ulcerations, whereas a pronounced influx of pro-inflammatory immune cell subsets such as lymphocytes, neutrophils, macrophages and monocytes into the intestinal mucosa and lamina propria of infected patients can be observed [7, 10]. In the past years, our understanding of the molecular mechanisms underlying campylobacteriosis was hampered by the scarcity of appropriate in vivo models. Murine models of C. jejuni infection exhibit some disadvantages such as sporadic pathogenic colonization, absence of overt disease and/or lack of intestinal immunopathology [6, 11]. Adult mice (beyond 2 months of age) harboring a conventional intestinal microbiota display a strong physiological colonization resistance preventing the host from pathogenic infection . Colonization resistance, however, can be overcome following modulation of the conventional intestinal microbiota by several means. For instance, broad-spectrum antibiotic treatment depleting the intestinal microbiota subsequently facilitated stable C. jejuni colonization [12, 13]. Furthermore, conventional adult mice displaying elevated commensal E. coli loads in their gastrointestinal tract could be stably infected with C. jejuni, whereas control mice successfully expelled the pathogen within a few days postinfection (p.i.) [12–15]. Even though infected mice did not display overt symptoms of C. jejuni infection such as wasting or bloody diarrhea, for instance, distinct proinflammatory immune responses including a prominent influx of innate and adaptive immune cell populations into the large intestinal mucosa and lamina propria, increased colonic secretion of pro-inflammatory cytokines and higher abundances of colonic epithelial apoptotic cells could be observed postinfection, hence mimicking immunopathological key features of human campylobacteriosis [12, 13].
Our group recently showed that IL-23p19, IL-22 and IL-18 were upregulated in the colon of C. jejuni infected gnotobiotic (i.e. secondary abiotic) mice , whereas IL-22 was upregulated in C. jejuni infected IL-10 deficient mice . IL-22 is a member of the IL-10 cytokine family and known for its antimicrobial and tissue-protective, but also pro-inflammatory properties [18, 19]. Notably, IL-22 acts literally like a double-edged sword in the intestinal tract depending on the respective compartment. Namely, in the colon, IL-22 exerts its anti-inflammatory properties , whereas in the small intestines, however, IL-22 acts as an pro-inflammatory mediator, given that in acute murine ileitis following peroral high dose Toxoplasma gondii infection, immunopathology was characterized by an IL-23p19 dependent IL-22 up-regulation leading to small intestinal necrosis [20, 21]. Whereas IL-22 further induced the expression of IL-18 mRNA in intestinal epithelial cells during T. gondii ileitis, IL-18 amplified IL-22 production from innate lymphoid cells (ILCs) and T helper (Th) -1 cell mediated intestinal inflammation . It is, however, not known yet, whether such a mutual regulation between IL-22 and IL-18 might also apply during C. jejuni infection.
In the present study we therefore aimed to shed further light onto the impact of cytokines belonging to the IL-23/IL-22/IL-18 axis during C. jejuni infecton. To address this, we infected conventional IL-23p19−/−, IL-22−/−, IL-18−/− and corresponding wildtype (WT) mice perorally with C. jejuni strain ATCC 43431 and investigated (1) the gastrointestinal colonization and translocation properties of C. jejuni as well as of commensal E. coli facilitating pathogenic infection, (2) the clinical outcome, (3) the subsequent apoptotic changes of the colon epithelium, (4) the abundances of distinct immune cell populations in the colonic mucosa and lamina propria, and finally (5) the large intestinal expression of inflammatory and regulatory cytokines.
All animal experiments were conducted according to the European Guidelines for animal welfare (2010/63/EU) with approval of the commission for animal experiments headed by the “Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin, registration number G0135/10). Animal welfare was monitored twice daily by assessment of clinical conditions.
Mice and C. jejuni infection
Female IL-23p19−/−, IL-22−/− and IL-18−/− mice (all in C57BL/6j background) as well as age- and sex-matched C57BL/6j WT control mice, all harboring a conventional intestinal microbiota, were bred and maintained within the same specific pathogen free (SPF) unit in the Forschungseinrichtungen für Experimentelle Medizin (FEM), Charité—University Medicine Berlin. In order to confirm absence of IL-23p19, IL-22 or IL-18 gene expresion, genomic DNA was isolated and disruption of either gene confirmed by polymerase chain reaction (PCR) . On 3 consecutive days (days 0, 1 and 2) mice were perorally infected with 109 colony forming units (CFU) of viable C. jejuni strain ATCC 43431 in a volume of 0.3 mL phosphate buffered saline (PBS) by gavage as described earlier .
Mice were sacrificed at day 14 p.i. by isofluran treatment (Abbott, Greifswald, Germany). Cardiac blood and tissue samples from colon, mesenteric lymph nodes (MLNs), spleen, liver and kidney were asserved under sterile conditions. Colonic ex vivo biopsies were collected in parallel for immunohistochemical, microbiological, and immunological analyses. Immunohistopathological changes were assessed in sections (5 μm) of colonic samples that were immediately fixed in 5 % formalin and embedded in paraffin.
In situ immunohistochemical analysis of colonic paraffin sections was performed as described previously [16, 22, 23]. Primary antibodies against cleaved caspase-3 (Asp175, Cell Signaling, Beverly, MA, USA, 1:200), Ki67 (TEC3, Dako, Denmark, 1:100), myeloperoxidase (MPO-7, #A0398, Dako, 1:500), and F4/80 (#14-4801, clone BM8, eBioscience, San Diego, CA, USA, 1:50) were used. For each animal, the average number of positively stained cells within at least six high power fields (HPF, 0.287 mm2, 400× magnification) were determined microscopically by a double-blinded investigator.
Quantitative analysis of bacterial colonization and translocation
Viable C. jejuni were detected in feces over time p.i. or luminal colonic samples at time of necropsy (day 14 p.i.), dissolved in sterile PBS and serial dilutions cultured on Karmali- and Columbia-agar supplemented with 5 % sheep blood (Oxoid) for 2 days at 37 °C under microaerobic conditions using CampyGen gas packs (Oxoid). To quantify bacterial translocation, ex vivo biopsies derived from MLNs, spleen, liver and kidney were homogenized in 1 mL sterile PBS, whereas cardiac blood (≈100 μL) was directly streaked onto Karmali-Agar and Columbia-Agar supplemented with 5 % sheep blood, and additionally tranferred to thioglycollate broths and cultivated accordingly. Viable Escherichia coli were quantitatively assessed as described earlier . The respective weights of fecal or tissue samples were determined by the difference of the sample weights before and after asservation. The detection limit of viable pathogens by direct plating was ≈100 CFU per g.
Cytokine detection in supernatants of colonic ex vivo biopsies
Colonic ex vivo biopsies were cut longitudinally, and washed in PBS. Strips of approximately 1 cm2 intestinal tissue were placed in 24-flat-bottom well culture plates (Nunc, Wiesbaden, Germany) containing 500 μL serum-free RPMI 1640 medium (Gibco, life technologies, Paisley, UK) supplemented with penicillin (100 U/mL) and streptomycin (100 µg/mL; PAA Laboratories). After 18 h at 37 °C, culture supernatants or serum samples were tested for TNF by the Mouse Inflammation Cytometric Bead Assay (CBA; BD Biosciences) on a BD FACSCanto II flow cytometer (BD Biosciences).
RNA was isolated from snap frozen colonic ex vivo biopsies, reverse transcribed and analyzed as described previously . Murine IL-23p19, IL-22, and IL-18 mRNA expressions were detected by real-time polymerase chain reaction (PCR) with specific primers and quantified by analysis with the light cycler data analysis software (Roche). The mRNA of the housekeeping gene for hypoxanthine-phosphoribosyltransferase (HPRT) was used as reference, the mRNA expression levels of the individual genes were normalized to the lowest measured value and expressed as fold expression (arbitrary units).
Medians and levels of significance were determined using Mann–Whitney test (GraphPad Prism v6.05, La Jolla, CA, USA) as indicated. Two-sided probability (P) values <0.05 were considered significant.
Colonization and translocation properties of C. jejuni in conventionally colonized mice lacking IL-23p19, IL-22 or IL-18
In the present study we investigated the role of cytokines belonging to the IL-23/IL-22/IL-18 axis within the interplay of C. jejuni infection, the host innate immune system, and the intestinal microbiota. To address this, adult (i.e. 3-months old) IL-23p19−/−, IL-22−/−, IL-18−/− and WT mice harboring a conventional microbiota were perorally challenged with 109 CFU of C. jejuni strain ATCC 43431 on 3 consecutive days (day 0, 1 and 2) by gavage. As early as 24 h following the latest infection (i.e. day 3 p.i.), already 50 % of WT mice had expelled the pathogen from their intestinal tract and were all culture-negative by day 10 p.i., whereas C. jejuni could be isolated from fecal samples at median loads of 104 to 105 CFU per gram in more than 70 % of IL-23p19−/− and 100 % of IL-22−/− and IL-18−/− mice until the end of the experiment (Fig. 1). At day of necropsy (i.e. day 14 p.i.), C. jejuni loads assessed in luminal samples derived from the colon and ileum were higher in either gene-deficient mice as compared to WT controls (p < 0.05–0.001; Fig. 2). Moreover, IL-22−/− and IL-18−/− mice harbored higher pathogenic loads in the duodenum than WT mice (p < 0.005 and 0.001, respectively; Fig. 2). Interestingly, viable C. jejuni could be isolated from 14.3, 33.3, and 8.3 % of MLNs taken from IL-23p19−/−, IL-22−/−, and IL-18−/− mice, respectively, but in none of WT control animals at day 14 p.i. (Figure 2d). Notably, irrespective of their genotype, mice were not compromized upon infection and did not exhibit symptoms of campylobacteriosis such as bloody diarrhea (not shown).
We next investigated whether C. jejuni were able to translocate from the intestinal tract to extra-intestinal compartments. In single cases, viable bacteria could be isolated from spleen (28.6 and 16.7 %), liver (14.3 and 16.7 %), and kidney (14.3 and 25.0 %) of IL-23p19−/− and IL-22−/− mice, respectively, but none of IL-18−/− and WT animals by direct plating (Additional file1: Fig. S1). Notably, all blood cultures were C. jejuni culture-negative as assessed by direct plating plus enrichment broths (Additional file 1: Fig. S1). Hence, C. jejuni was able to stably colonize the intestines of virtually all IL-22−/− and IL-18−/−, approximately 75 % of IL-23p19−/−, but not WT mice, with highest luminal loads within the large intestines. Only in single cases, however, viable pathogen could be detected in extra-intestinal compartments, but never in cardiac blood.
Intestinal commensal E. coli loads in conventionally colonized mice lacking IL-23p19, IL-22 or IL-18
We next addressed the question whether the difference in susceptibiliy to C. jejuni infection observed in gene-deficient and WT mice was due to the respective loads of enterobacteria such as E. coli derived from the intestinal commensal microbiota. In fact, naive IL-22−/− mice harbored the highest fecal E. coli loads when compared to the remaining groups of mice (p < 0.001; Fig. 3). Interestingly, in IL-18−/− mice lower fecal enterobacterial burdens could be assessed as compared to IL-23p19−/− mice, and furthermore, no enterobacteria at all were isolated in 22.2 % of fecal samples taken from naive IL-18−/− animals by direct plating (Fig. 3). At day of necropsy, E. coli loads in duodenum, ileum and colon were higher in IL-23p19−/− and IL-22−/− mice as compared to IL-18−/− and WT animals (p < 0.005–0.001; Fig. 4a–c). Moreover, viable E. coli could be cultured from MLNs in 14.3 % of IL-23p19−/− and 41.7 % of IL-22−/− mice (Fig. 4d). As for C. jejuni infection, commensal E. coli translocated from the intestines to extra-intestinal compartments such as spleen, liver and kindey in single cases only, but could never be detected in cardiac blood (Additional file 2: Fig. S2).
Taken together, IL-22−/− mice that were highly susceptible to stable C. jejuni infection displayed higher intestinal enterobacterial concentrations as compared to colonization resistent WT mice. In fecal samples of some IL-18−/− mice that could also be readily colonized by the pathogen, however, commensal enterobacteria could not be detected by direct plating pointing towards additional factors rendering the host susceptible to pathogenic infection.
Microscopic sequelae of C. jejuni infection in conventional mice lacking IL-23p19, IL-22 or IL-18
We next determined C. jejuni induced histopathology in colonic ex vivo biopsies. To address this, colonic paraffin sections were stained for caspase-3 by in situ immunhistochemistry in order to quantitate apoptosis in colonic epithelium, a well recognized diagnostic marker in the histopathological evaluation and grading of intestinal disease including campylobacteriosis . Following C. jejuni infection, apoptotic cell numbers increased in WT, but not in mice lacking IL-23p19, IL-22 or IL-18 (p < 0.005), with lowest colonic epithelial counts in IL-22−/− mice at day 14 p.i. (p < 0.005 vs remaining groups; Fig. 5a). Conversely, IL-22−/−, but also IL-23p19−/− mice displayed higher numbers of Ki67-positive cells in colonic epithelial layers as compared to WT mice (p < 0.005; Fig. 5b), indicative for more pronounced cellular proliferation. Hence, despite highest intestinal pathogenic loads, IL-22−/− mice did not exhibit C. jejuni induced intestinal apoptosis, but on the contrary, even higher cell proliferating responses as potential measure counteracting eventual cell damage.
Colonic pro-inflammatory immune responses upon C. jejuni infection of conventional mice lacking IL-23p19, IL-22 or IL-18
Given that recruitment of pro-inflammatory immune cells to sites of inflammation is a hallmark of campylobacteriosis , we next surveyed the numbers of distinct innate immune cell populations by in situ immunohistochemical staining of colonic biopsies. Following C. jejuni infection, numbers of colonic MPO7-positive neutrophils increased in WT, IL-22−/− and IL-18−/−, but not IL-23p19−/− mice (p < 0.05−0.005; Fig. 6a). At day 14 p.i., colonic neutrophil numbers were lower in IL-23p19−/− and IL-22−/− as compared to WT mice (p < 0.005; Fig. 6a). Moreover, numbers of F4/80-positive macrophages and monocytes increased in large intestinal mucosa and lamina propria of infected mice (p < 0.005), but did not differ between genotypes at day 14 p.i. (Figure 6b).
We next measured secretion of the pro-inflammatory cytokine TNF in colonic ex vivo biopsies following C. jejuni infection. WT and IL-23p19−/−, but not IL-22−/− and IL-18−/− mice displayed C. jejuni-induced inreased colonic TNF concentrations (p < 0.005; Fig. 7). At day 14 p.i., IL-22−/− mice exhibited lower TNF levels in their large intestines as compared to the remaining infected groups (p < 0.05–0.005; Fig. 7).
Colonic expression on IL-23p19, IL-22 and IL-18 in C. jejuni infected conventional mice lacking IL-23p19, IL-22 or IL-18
We next addressed whether colonic IL-23p19, IL-22 and IL-18 mRNA were differentially expressed in IL-23p19−/−, IL-22−/− and IL-18−/− mice upon C. jejuni infection. In infected IL-22−/− mice, colonic IL-23p19 was down-regulated and mRNA expression levels lower as compared to infected WT mice (p < 0.005; Fig. 8a). In naive and infected IL-23p19−/−, but not IL-18−/− mice, colonic IL-22 mRNA levels were lower as compared to the respective WT controls (p < 0.005; Fig. 8b). In naive and infected IL-22−/−, but not IL-23p19−/− mice, however, lower IL-18 mRNA concentrations could be measured as compared to naive and infected WT animals, respectively (p < 0.05; Fig. 8c). Hence, cytokines of the IL-23/IL-22/IL-18 axis appear in fact to be differentially expressed and regulated during C. jejuni infection.
Cytokines of the IL-23/IL-22/IL-18 axis are pivotally involved in host defence and in mediating and regulating inflammatory immune responses upon bacterial and parasitic infection [21, 25, 26]. We here investigated whether IL-23, IL-22 and IL-18 were actors in the orchestrated interplay between C. jejuni, host microbiota and immune system. Interestingly, conventionally colonized mice lacking IL-23p19, IL-22 or IL-18, but not WT control mice were susceptible to C. jejuni infection and could be readily colonized with highest bacterial loads in the terminal ileum and colon. In line with our previous studies, physiological colonization resistance prevented WT mice harboring a conventional intestinal microbiota from pathogenic infection [12, 15]. Modulation of the intestinal microbiota towards elevated luminal commensal enterobacterial (i.e. E. coli) loads, however, was a sufficient way to override colonization resistance, given that C. jejuni infection was facilitated upon feeding conventional adult mice viable E. coli via the drinking water  or a Western style diet, for instance . Interestingly, only susceptible IL-22−/−, but neither IL-23p19−/−, nor IL-18−/− mice harbored elevated commensal intestinal E. coli loads when compared to resistant WT mice. This is well in line with a previous report showing an elevated abundance of the phylum Proteobacteria such as commensal E. coli in the intestines of IL-22−/− mice . An altered microbiota composition rendered IL-22−/− mice even more susceptible to colitis development than WT mice and can be explained by the fact that IL-22 plays a critical role in regulating the host microbiota composition due to its important antimicrobial properties including induction of antimicrobial peptides such as β-defensins, but also of the mucosal barrier forming mucins [27–30]. Hence, other so far unidentified host-related factors might predispose IL-18−/−, but also IL-23p19−/− mice to C. jejuni infection.
We have recently shown that 3-weeks-old conventional infant mice develop self-limiting acute enteritis within 1 week following peroral C. jejuni infection immediately after weaning [15, 31, 32]. Notably, infant mice also harbored higher intestinal commensal E. coli loads in their gastrointestinal tract as compared to adult mice, subsequently facilitating C. jejuni infection [15, 31, 32]. As shown by us previously, colonic IL-23p19, IL-22 and IL-18 mRNA were upregulated in C. jejuni infected infant mice . Moreover, following peroral infection of conventional adult mice with Arcobacter butzleri sharing taxonomic relationships to Campylobacterales, cytokines of the IL-23/IL-22/IL-18 axis were regulated not only in a strain and time course of infection, but also tissue dependent fashion. Whereas in the colon IL-22 and IL-18 were up-regulated upon A. butzleri infection, IL-23p19 and IL-22 mRNA levels increased in the small intestines of infected conventional adult WT mice [33, 34].
In our present study, despite stable C. jejuni infection, mice lacking IL-23p19, IL-22 or IL-18 exhibited even lower colonic epithelial apoptotic cell numbers as compared to WT mice at day 14 p.i., whereas higher numbers of proliferating cells could be observed in the colonic epithelium of infected IL-22−/− mice, thereby counteracting potential C. jejuni induced cell death. These results are in part supported by our recent study in infant mice that were infected with a different C. jejuni strain (namely 81–176): 2 weeks following peroral infection, less pronounced colonic apoptosis and conversely, more distinct proliferative measures could be observed in the large intestines of infant IL-22−/−, but also IL-18−/− as compared to WT mice . In fact it is somewhat surprising that even though the pathogen was expelled from the intestinal tract of infected infant WT mice here, increased numbers of colonic epithelial apoptotic cells could be observed. This observation, however, is well in line with results from our previous studies in different infection models [22, 35, 36]. We hypothesize that the pathogen does not necessarily need to be permanently abundant in the intestinal tract to evoke (early) host responses with subsequent pro-inflammatory sequelae and tissue damage including intestinal apoptosis. Hence, it is rather the initial hit of infection that tips the balance towards immunopathological responses and potential counter-regulatory (i.e. proliferative) measures postinfection [22, 35, 36].
Here, less distinct colonic epithelial apoptosis were accompanied by lower abundance of neutrophilic granulocytes within the large intestinal mucosa and lamina propria of infected IL-23p19−/− and IL-22−/− as compared to WT control mice, and paralleled by lower colonic TNF secretion in IL-22−/− and IL-18−/− mice than in WT animals, which also held true during the early phase (i.e. day 6) of C. jejuni infection of infant mice .
The cytokines of the IL-23/IL-22/IL-18 axis appear in fact to be differentially expressed and regulated during murine C. jejuni infection. Our present study revealed that (1) colonic IL-23p19 mRNA expression was lower in infected IL-22−/− mice than WT mice (2) and vice versa, i.e. IL-22 mRNA was lower in IL-23p19−/− vs. WT mice at day 14 p.i., whereas (3) IL-18 mRNA was down-regulated in large intestines of naive and infected IL-22−/− mice. These data are in part supported by results derived from the infant mouse infection model, given that in naive as well as in C. jejuni infected infant IL-22−/− mice, colonic IL-23p19 and IL-18 mRNA were down-regulated, which also held true for IL-18 mRNA expression levels in naive and infected infant IL-23p19−/− as compared to WT control mice . It is most likely that the observed differences in expression data derived from infection studies with infant versus adult mice are due to age-dependent differences in host-factors including intestinal microbiota compositon and subsequently the intraluminal milieu as well as the maturity of immune cell subsets and cells producing antimicrobial peptides for instance. Information about the distinct regulatory pathways within the IL-23/IL-22/IL-18 axis following bacterial (i.e. C. jejuni) infection are very limited. Whereas IL-23 was highlighted as a key regulator of mucosal immune responses following intestinal infection and inflammation  including T. gondii induced ileitis , IL-22 was shown to be effective in antimicrobial defense directed against C. jejuni . Moreover, in human intestinal ex vivo biopsies IL-22 was upregulated upon C. jejuni infection , whereas elevated IL-22 concentrations were observed in the intestines of C. jejuni infected IL-10−/− mice . Data regarding the role of IL-18 in C. jejuni-host interaction, however, are scarce. C. jejuni infection of three different cell lines derived from pre-malignant Barret’s esophagus was accompanied by an up-regulation of IL-18 gene expression . Following infection of differentiated THP-1 macrophages with an adherent and invasive C. concisus strain, genes encoding IL-23 and IL-18, but not IL-22, were regulated as assessed by transcriptomic and proteomic analyses . Our previous A. butzleri infection studies in gnotobiotic IL-10−/− mice further revealed that in the colon IL-18 mRNA levels were elevated during both the early and late phase of infection, whereas colonic IL-22 mRNA was upregulated during the former only [33, 34].
In conclusion, the regulatory pathways within the IL-23/IL-22/IL-18 axis following C. jejuni infection need to be further unraveled in future studies in order to improve our understanding of the distinct molecular mechanisms underlying campylobacteriosis.
innate lymphoid cells
polymerase chain reaction
colony forming units
phosphate buffered saline
mesenteric lymph nodes
Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nature Rev Microbiol. 2007;5:665–79.
Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010;2010(300):205–11.
Lane JA, Mehra RK, Carrington SD, Hickey RM. The food glycome: a source of protection against pathogen colonization in the gastrointestinal tract. Int J Food Microbiol. 2010;142:1–13.
Guerry P, Szymanski CM. Campylobacter sugars sticking out. Trends Microbiol. 2008;16:428–35.
Alter T, Bereswill S, Glunder G, Haag LM, Hanel I, Heimesaat MM, Lugert R, Rautenschlein S, Weber RM, Zautner AE, Gross U. Campylobacteriosis of man: livestock as reservoir for Campylobacter species. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2011;54:728–34.
Kist M, Bereswill S. Campylobacter jejuni. Contrib Microbiol. 2001;8:150–65.
van Spreeuwel JP, Duursma GC, Meijer CJ, Bax R, Rosekrans PC, Lindeman J. Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut. 1985;26:945–51.
Ketley JM. Pathogenesis of enteric infection by Campylobacter. Microbiology. 1997;143:5–21.
Wakerley BR, Uncini A, Yuki N, Group GBSC, Group GBSC. Guillain-Barré and Miller Fisher syndromes—new diagnostic classification. Nature Rev Neurol. 2014;10:537–44.
Walker RI, Caldwell MB, Lee EC, Guerry P, Trust TJ, Ruiz-Palacios GM. Pathophysiology of Campylobacter enteritis. Microbiol Rev. 1986;50:81–94.
Dorrell N, Wren BW. The second century of Campylobacter research: recent advances, new opportunities and old problems. Curr Opin Infect Dis. 2007;20:514–8.
Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kuhl AA, Dasti JI, Zautner AE, Munoz M, Loddenkemper C, Gross U, Gobel UB, Heimesaat MM. Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One. 2011;6:e20953.
Masanta WO, Heimesaat MM, Bereswill S, Tareen AM, Lugert R, Gross U, Zautner AE. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol. 2013;2013:526860.
Bereswill S, Plickert R, Fischer A, Kuhl AA, Loddenkemper C, Batra A, Siegmund B, Gobel UB, Heimesaat MM. What you eat is what you get: novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. Eur J Microbiol Immunol (Bp). 2011;1:237–48.
Haag LM, Fischer A, Otto B, Plickert R, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One. 2012;7:e35988.
Alutis ME, Grundmann U, Fischer A, Hagen U, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM. The role of gelatinases in Campylobacter jejuni infection of gnotobiotic mice. Eur J Microbiol Immunol (Bp). 2015;5:256–67.
Malik A, Sharma D, St Charles J, Dybas LA, Mansfield LS. Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity. Mucosal Immunol. 2014;7:802–17.
Ouyang WJ, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of Cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71–109.
Eidenschenk C, Rutz S, Liesenfeld O, Ouyang W. Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol. 2014;380:213–36.
Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Holscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med. 2009;206:3047–59.
Munoz M, Eidenschenk C, Ota N, Wong K, Lohmann U, Kuhl AA, Wang X, Manzanillo P, Li Y, Rutz S, Zheng Y, Diehl L, Kayagaki N, van Lookeren-Campagne M, Liesenfeld O, Heimesaat M, Ouyang W. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity. 2015;42:321–31.
Alutis ME, Grundmann U, Hagen U, Fischer A, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM. Matrix metalloproteinase-2 mediates intestinal immunopathogenesis in Campylobacter jejuni-infected infant mice. Eur J Microbiol Immunol (Bp). 2015;5:188–98.
Heimesaat MM, Fischer A, Alutis M, Grundmann U, Boehm M, Tegtmeyer N, Gobel UB, Kuhl AA, Bereswill S, Backert S. The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice. Gut Pathog. 2014;6:16.
Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Gobel UB, Liesenfeld O. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol. 2006;177:8785–95.
Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30:196–203.
Atarashi K, Tanoue T, Honda K. Induction of lamina propria Th17 cells by intestinal commensal bacteria. Vaccine. 2010;28:8036–8.
Zenewicz LA, Yin X, Wang G, Elinav E, Hao L, Zhao L, Flavell RA. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol. 2013;190:5306–12.
Zilbauer M, Dorrell N, Boughan PK, Harris A, Wren BW, Klein NJ, Bajaj-Elliott M. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun. 2005;73:7281–9.
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282–9.
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534–44.
Haag LM, Fischer A, Otto B, Grundmann U, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp). 2012;2:2–11.
Heimesaat MM, Haag LM, Fischer A, Otto B, Kuhl AA, Gobel UB, Bereswill S. Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Eur J Microbiol Immunol (Bp). 2013;3:174–82.
Heimesaat MM, Alter T, Bereswill S, Gölz G. Intestinal expression of genes encoding inflammatory mediators and gelatinases during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice. Eur J Microbiol Immunol (Bp). 2016;6:56–66.
Gölz G, Alter T, Bereswill S, Heimesaat MM. Toll-like receptor-4 dependent gene expression during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice. Eur J Microbiol Immunol. 2016;6:67–80.
Heimesaat MM, Alutis ME, Grundmann U, Fischer A, Göbel UB, Bereswill S. The role of IL-23, IL-22 and IL-18 in Campylobacter jejuni infection of conventional infant mice. Eur J Microbiol Immunol (Bp). 2016. doi:10.1556/1886.2016.00008.
Heimesaat MM, Grundmann U, Alutis ME, Fischer A, Göbel UB, Bereswill S. Colonic expression of genes encoding inflammatory mediators and gelatinases during Campylobacter jejuni infection of conventional infant mice. Eur J Microbiol Immunol (Bp). 2016. doi:10.1556/1886.2016.00009.
Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010;464:1371–5.
Edwards LA, Nistala K, Mills DC, Stephenson HN, Zilbauer M, Wren BW, Dorrell N, Lindley KJ, Wedderburn LR, Bajaj-Elliott M. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One. 2010;5:e15398.
Mozaffari Namin B, Soltan Dallal MM, Ebrahimi Daryani N. The effect of Campylobacter concisus on expression of IL-18, TNF-alpha and p53 in Barrett′s cell lines. Jundishapur J Microbiol. 2015;8:e26393.
Kaakoush NO, Deshpande NP, Man SM, Burgos-Portugal JA, Khattak FA, Raftery MJ, Wilkins MR, Mitchell HM. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus. Infect Immun. 2015;83:832–45.
Conceived and designed the experiments: SB MMH; Performed the experiments: MEA UG AF MMH; Analyzed the data: SB UG MEA AF MMH; Contributed reagents/materials/analysis tolls: UBG; Wrote the paper: SB MMH. All authors read and approved the final manuscript.
We thank Michaela Wattrodt, Ursula Rüschendorf, Silvia Schulze, Alexandra Bittroff-Leben, Ines Puschendorf, Gernot Reifenberger, Uwe Lohmann, and the staff of the animal research facility at Charité—University Medicine Berlin for excellent technical assistance and animal breeding. We are grateful to Simone Spieckermann for immunohistochemical staining of paraffin sections.
Financial disclosure, Grant support
This work was supported by grants from the German Research Foundation (DFG) to AF, SB and UBG (SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6), AEK and UG (SFB633, Immuco), and from the German Federal Ministery of Education and Research (BMBF) to SB (TP1.1).
The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Availability of data and materials
The data will be shared upon personal request.
The authors declare that they have no competing interests.
Additional file 1: Figure S1. Extraintestinal translocation of viable intestinal C. jejuni strain 81–176 in perorally infected mice lacking IL-23p19, IL-22 or IL-18. Conventional wildtype (WT), IL-23p19−/−, IL-22−/− and IL-18−/− mice were perorally infected with C. jejuni strain 81–176 by gavage at day 0 and day 1. Pathogenic translocation to extraintestinal compartments was assessed by determining C. jejuni strain 81–176 loads (CFU, colony forming units per gram) in (A) spleen (B) liver (C) kidney, and (D) cardiac blood at day 14 postinfection by culture. Numbers of mice harboring the pathogen out of the total number of analyzed animals are given in parentheses.
Additional file 2: Figure S2. Extraintestinal translocation of viable intestinal commensal E. coli in perorally C. jejuni strain 81-176 infected mice lacking IL-23p19, IL-22 or IL-18. Conventional wildtype (WT), IL-23p19−/−, IL-22−/− and IL-18−/− mice were perorally infected with C. jejuni strain 81-176 by gavage at day 0 and day 1. Intestinal translocation of viable E. coli derived from the commensal intestinal microbiota to extraintestinal compartments was assessed by determining bacterial loads (CFU, colony forming units per gram) in (A) spleen (B) liver (C) kidney, and (D) cardiac blood at day 14 postinfection by culture. Numbers of mice harboring E. coli out of the total number of analyzed animals are given in parentheses, and medians (black bars) are indicated. Data were pooled from three independent experiments.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Heimesaat, M.M., Grundmann, U., Alutis, M.E. et al. The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection. Gut Pathog 8, 21 (2016). https://doi.org/10.1186/s13099-016-0106-4
- Campylobacter jejuni
- In vivo infection
- IL-23/IL-22/IL-18 axis
- Pro-inflammatory immune responses
- Systemic immune responses
- Intestinal microbiota
- Colonization resistance